<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04585828</url>
  </required_header>
  <id_info>
    <org_study_id>71051</org_study_id>
    <nct_id>NCT04585828</nct_id>
  </id_info>
  <brief_title>Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy</brief_title>
  <official_title>Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy for Treatment of Neonatal Hyperbilirubinemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized study of phototherapy for neonatal hyperbilirubinemia. The intervention group is&#xD;
      treated with a double pad fiber optic device and the control group with conventional blue&#xD;
      ligt phototherapy from above. Both treatments are well known and used. The primary outcome is&#xD;
      to explore the parents experience with the two different treatment modalities by&#xD;
      questionnaires.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire on the parents experience with the phototherapy treatment</measure>
    <time_frame>Day 1 of phototherapy</time_frame>
    <description>Parents experience of phototherapy.&#xD;
Questions at time of beginning phototherapy (1):&#xD;
&quot;What did you feel at the time your baby started treatment with phototherapy?&quot;&#xD;
Questions after phototherapy (2):&#xD;
&quot;What did you experience with your baby during the time of phototherapy?&quot;&#xD;
The parents answer on a scale from &quot;I agree, I partly agree, N/A, I partly disagreee, I disagree&quot;&#xD;
Examples of questions:&#xD;
&quot;I felt well informed about the indication and use of phototherapy&quot; (Answer: I agree, partly agree, disagreee etc,)&#xD;
&quot;I was difficult to breastfeed while my baby was on phototherapy&quot; (Answer as above described)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of phototherapy</measure>
    <time_frame>Measurement of bilirubin before phototherapy and after 24 hours</time_frame>
    <description>Change in total serum bilirubin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Neonatal Hyperbilirubinemia</condition>
  <arm_group>
    <arm_group_label>Bili Cocoon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The infants will be treated with phototherapy using a double sided fiber optic pad called Bili Cocoon with an irradiance of 30 uW/cm2/nm from both sides.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional blue light</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The infants will be treated with blue light from above at 30 Uw/cm2/nm which is the standard treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy with double sided fiber optic pads with blue light at irradiance 30 uW/cm2/nm using Bili Cocoon</intervention_name>
    <description>The baby will be treated with Bilicocoon for 24 hours. Decrease of total serum biliurubin will be evalueated hereafter.</description>
    <arm_group_label>Bili Cocoon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy from above using NeoBlue at irradiance of 30 uW/cm2/nm</intervention_name>
    <description>The baby will be treated with phototherapy from above for 24 hours. Decrease of total serum bilirubin will be evaluated hereafter.</description>
    <arm_group_label>Conventional blue light</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Neonatal icterus and total serum bilirubin above threshold for phototherapy.&#xD;
&#xD;
          -  Gestational age ≥ 33 weeks&#xD;
&#xD;
          -  Birth weight ≥ 1800 gr&#xD;
&#xD;
          -  Postnatal age &gt; 24 hours and &lt; 2 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemolysis due to isoimmunization&#xD;
&#xD;
          -  Very high or rapidly rising total serum bilirubin&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperbilirubinemia, Neonatal</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

